Diagnostic, treatment, and follow-up of osteoporosis-position statement of the Latin American Federation of Endocrinology
- PMID: 34302550
- DOI: 10.1007/s11657-021-00974-x
Diagnostic, treatment, and follow-up of osteoporosis-position statement of the Latin American Federation of Endocrinology
Abstract
The Latin American Federation of Endocrinology position statement on osteoporosis was developed by endocrinologists from 9 countries. It encompasses the definition, diagnosis, treatment, and follow-up of the disease, the identification of barriers to healthcare, and proposals to improve the disease care in the region.
Introduction: There is a gap in the understanding of osteoporosis in Latin America. The objective of this work is to state the position of the Latin American Federation of Endocrinology on osteoporosis care in postmenopausal women to better bridge this gap.
Methods: An experts' panel was formed comprising of 11 endocrinologists from 9 countries. A data search was conducted with a conceptual approach and data selection was based on the hierarchy of the EBHC pyramid. Unpublished data was considered for local epidemiological data and expert opinion for the identification of barriers to healthcare. An expert consensus based on the Delphi methodology was carried out. Experts were asked to respond on a 5-point Likert Scale to two provided answers to guiding questions.
Results: Consensus was agreed on the answer for the questions with the higher median on the Likert scale and synthetized on 16 statements covering the definition of osteoporosis, diagnostic approach, treatment options, and follow-up. Besides clinical topics, unmet needs in osteoporosis were identified in relation to local epidemiological data, barriers to treatment, and misclassification of programs within health systems.
Conclusions: Through a process based on recognized methodological tools, FELAEN's position on osteoporosis was developed. This made it possible to state an optimum scenario for the care of the disease and helped to identify knowledge gaps. There is great variability in the approach to osteoporosis in Latin America and barriers in all the stages of healthcare persist.
Keywords: Bone density conservation agents; Bone diseases; Densitometry; Health services; Osteoporotic fractures.
© 2021. International Osteoporosis Foundation and National Osteoporosis Foundation.
Comment in
-
Position statement of the Latin American Federation of Endocrinology on osteoporosis.Arch Osteoporos. 2021 Sep 25;16(1):142. doi: 10.1007/s11657-021-01008-2. Arch Osteoporos. 2021. PMID: 34564783 No abstract available.
Similar articles
-
Position statement of the Latin American Federation of Endocrinology on osteoporosis.Arch Osteoporos. 2021 Sep 25;16(1):142. doi: 10.1007/s11657-021-01008-2. Arch Osteoporos. 2021. PMID: 34564783 No abstract available.
-
Consensus statement: osteoporosis prevention and treatment in Latin America-current structure and future directions.Arch Osteoporos. 2018 Aug 24;13(1):90. doi: 10.1007/s11657-018-0505-x. Arch Osteoporos. 2018. PMID: 30143914 Free PMC article. Review.
-
Position Statement of the Latin American Federation of Endocrinology on Osteoporosis: Response to comments by López Gavilánez.Arch Osteoporos. 2021 Dec 10;17(1):3. doi: 10.1007/s11657-021-01011-7. Arch Osteoporos. 2021. PMID: 34888731 No abstract available.
-
Baseline characteristics of postmenopausal women with osteoporosis treated with teriparatide in a real-world setting in Latin America: a subregional analysis from the Asia and Latin America Fracture Observational Study (ALAFOS).Adv Rheumatol. 2019 Nov 8;59(1):46. doi: 10.1186/s42358-019-0088-2. Adv Rheumatol. 2019. PMID: 31703737
-
Osteoporosis prevention, diagnosis, and therapy.NIH Consens Statement. 2000 Mar 27-29;17(1):1-45. NIH Consens Statement. 2000. PMID: 11525451 Review.
Cited by
-
First Ecuadorian consensus statement on the management of osteoporosis.Arch Osteoporos. 2023 Jul 28;18(1):106. doi: 10.1007/s11657-023-01315-w. Arch Osteoporos. 2023. PMID: 37505312 No abstract available.
-
Clinical Practice Guidelines of the Latin American Federation of Endocrinology for the use of vitamin D in the maintenance of bone health: recommendations for the Latin American context.Arch Osteoporos. 2024 Jun 8;19(1):46. doi: 10.1007/s11657-024-01398-z. Arch Osteoporos. 2024. PMID: 38850469 Free PMC article.
-
Vitamin D: Synthesis, deficiency, polymorphisms and resistance to its action in Latin American countries.Biomedica. 2024 Mar 31;44(1):5-9. doi: 10.7705/biomedica.7477. Biomedica. 2024. PMID: 38648341 Free PMC article. English, Spanish. No abstract available.
-
Position statement of the Latin American Federation of Endocrinology on osteoporosis.Arch Osteoporos. 2021 Sep 25;16(1):142. doi: 10.1007/s11657-021-01008-2. Arch Osteoporos. 2021. PMID: 34564783 No abstract available.
-
Apoptosis-associated genetic mechanisms in the transition from rheumatoid arthritis to osteoporosis: A bioinformatics and functional analysis approach.APL Bioeng. 2024 Nov 5;8(4):046107. doi: 10.1063/5.0233961. eCollection 2024 Dec. APL Bioeng. 2024. PMID: 39507523 Free PMC article.
References
-
- Aranco N, Stampini M, Ibarrarán P, Medellín N (2018) Panorama de envejecimiento y dependencia en América Latina y el Caribe
-
- Comisión Económica para América Latina y el Caribe (CEPAL) (2019) Anuario Estadístico de América Latina y el Caribe, 2018. Santiago
-
- Clark P, Denova-Gutiérrez E, Zerbini C, Sanchez A, Messina O, Jaller JJ et al (2018) FRAX-based intervention and assessment thresholds in seven Latin American countries. Osteoporos Int 29(3):707–15 - PubMed
-
- Clark P, Cons-Molina F, Deleze M, Ragi S, Haddock L, Zanchetta JR et al (2009) The prevalence of radiographic vertebral fractures in Latin American countries: The Latin American Vertebral Osteoporosis Study (LAVOS). Osteoporos Int 20(2):275–82 - PubMed
-
- International Osteoporosis Foundation (2012) Latin America Regional Audit
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous